PURPOSE: To evaluate the long-term outcomes of a modified technique for laser chorioretinal venous anastomosis in nonischemic central vein occlusion (CVO). DESIGN: Prospective, noncomparative, consecutive case series. PARTICIPANTS: Nineteen eyes of 19 patients. METHODS: Nineteen consecutive eyes with nonischemic CVO were observed for a mean period of 48 months after attempted laser-induced chorioretinal venous anastomosis therapy using a technique modified intentionally to avoid vein wall rupture. MAIN OUTCOME MEASURES: Anastomosis patency, visual acuity, maintenance of nonischemic status, and complications were measured. RESULTS: At least one patent anastomosis developed eventually in 19 of 19 eyes (100%). Two anastomoses developed in 5 of 19 eyes (26%). There were one or two nonfunctioning sites in 8 of 19 eyes (42%). The maximum number of treatment attempts in a single eye was four. Snellen visual acuity was unchanged in 3 of 19 eyes (16%) and improved from 1 to 11 lines (mean improvement, 5 lines) in 16 of 19 eyes (84%) during the mean follow-up period of 48 months. Nineteen of 19 eyes (100%) maintained nonischemic status. Treatment complications were limited to localized preretinal fibrosis. CONCLUSIONS: Rupture of the vein wall is not required to form a functioning laser-induced chorioretinal venous anastomosis in eyes with nonischemic CVO. A technique modified intentionally to avoid vein wall rupture seems to be safer and more predicable.
PURPOSE: To evaluate the long-term outcomes of a modified technique for laser chorioretinal venous anastomosis in nonischemic central vein occlusion (CVO). DESIGN: Prospective, noncomparative, consecutive case series. PARTICIPANTS: Nineteen eyes of 19 patients. METHODS: Nineteen consecutive eyes with nonischemic CVO were observed for a mean period of 48 months after attempted laser-induced chorioretinal venous anastomosis therapy using a technique modified intentionally to avoid vein wall rupture. MAIN OUTCOME MEASURES: Anastomosis patency, visual acuity, maintenance of nonischemic status, and complications were measured. RESULTS: At least one patent anastomosis developed eventually in 19 of 19 eyes (100%). Two anastomoses developed in 5 of 19 eyes (26%). There were one or two nonfunctioning sites in 8 of 19 eyes (42%). The maximum number of treatment attempts in a single eye was four. Snellen visual acuity was unchanged in 3 of 19 eyes (16%) and improved from 1 to 11 lines (mean improvement, 5 lines) in 16 of 19 eyes (84%) during the mean follow-up period of 48 months. Nineteen of 19 eyes (100%) maintained nonischemic status. Treatment complications were limited to localized preretinal fibrosis. CONCLUSIONS:Rupture of the vein wall is not required to form a functioning laser-induced chorioretinal venous anastomosis in eyes with nonischemic CVO. A technique modified intentionally to avoid vein wall rupture seems to be safer and more predicable.